| 000 -LEADER |
|---|
| fixed length control field |
03088nam a2200241uu 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
372 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20250213180606.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
001010s1995 xx ||||g| |0|| 0 eng d |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
|---|
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
5.02 |
| Local cutter number (OCLC) ; Book number/undivided call number, CALL (RLIN) |
V2156v |
| 999 ## - SYSTEM CONTROL NUMBERS (KOHA) |
|---|
| Koha Dewey Subclass [OBSOLETE] |
PHL2MARC21 1.1 |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Valuing health care : |
| Remainder of title |
costs, benefits, and effectiveness of pharmaceuticals and other medical technologies |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Cambridge : |
| Name of publisher, distributor, etc. |
Cambridge University, |
| Date of publication, distribution, etc. |
1995 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
273 p. |
| 505 80 - FORMATTED CONTENTS NOTE |
|---|
| Title |
Introduction |
| -- |
Major objectives of this book |
| -- |
Waht is cost-effectiveness/cost-benefit analysis ? |
| -- |
Chapter plan |
| -- |
Description of specific chapters |
| -- |
2 - Evidence of effectviness: evaluating is quality |
| -- |
Nature of the evidence |
| -- |
Quality of the evidence |
| -- |
Extensions of effectiveness evidence required for estimation of cost-effectiveness |
| -- |
Summary |
| -- |
3 - Utility assessment for estimating quality-adjusted life years |
| -- |
Conceptual framework |
| -- |
The concept of relative importance |
| -- |
The concept of utility |
| -- |
Methods for assessing utility |
| -- |
Psychological versus economic models |
| -- |
Cognitive limitations |
| -- |
Whose preferences should be used in the model ? |
| -- |
Fixed versus variable preference models |
| -- |
Application and criticism: the Oregon experiment |
| -- |
Summary |
| -- |
4 - Measuring costs |
| -- |
Ideals and realities in cost measurement |
| -- |
Practice advice for measuring costs |
| -- |
summary |
| -- |
5 - From cost-effectiveness ratios to resource allocation: where to draw the line ? |
| -- |
The basic cost-effectiveness model |
| -- |
Cost-effectiveness ratios form different perspectives |
| -- |
Incremental cost-effectiveness analysis |
| -- |
Determining a critical ratio |
| -- |
Cost-benefit or cost-effectiveness analysis ? |
| -- |
Conclusion |
| -- |
6 - Valuing health care benefits in money terms |
| -- |
Standards and definitions |
| -- |
The need and settigns for analysis |
| -- |
What difference does money make ? |
| -- |
Measuring benefits |
| -- |
Problems with willingness-to-pay measures |
| -- |
Insurance and cost-benefit analysis |
| -- |
Conclusion |
| -- |
7 - Discounting health effects for medical decisions |
| -- |
The rationale for discounting |
| -- |
Problems with the failure to discounting health effects for medical decisions |
| -- |
The rationale for discouting |
| -- |
Problems with the failure to discount |
| -- |
Discounting and medical decisions under uncertainly |
| -- |
Modeling and estimating rates of discount for health |
| -- |
Conclusion |
| -- |
8 - Statistical issues in cost-effectiveness contexts with biased risk perceptions |
| -- |
8 - Statistical issues in cost-effectiveness analyses |
| -- |
Estimation issues |
| -- |
Problems in using administrativeness analysis |
| -- |
Conclusion |
| -- |
9 - Decision trees and Markov models in cost-effectiveness research |
| -- |
Decision trees |
| -- |
Modeling long-term consequences |
| -- |
Appendix: further reading |
| -- |
10 - The use of cost-effectiveness/cost-benefit analysis in actual decision making: current status and prospects |
| -- |
Current applications of cost-effectiveness/cost-effectiveness/cost-benefit analysis in health policymaking |
| -- |
A brief research agenda |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| 9 (RLIN) |
12122 |
| Topical term or geographic name entry element |
Política de Saúde |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| 9 (RLIN) |
12964 |
| Topical term or geographic name entry element |
Custo-Benefício |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| 9 (RLIN) |
12703 |
| Topical term or geographic name entry element |
Eficácia |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| 9 (RLIN) |
12404 |
| Topical term or geographic name entry element |
Tomada de Decisão |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
|
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Livro Geral |
| 998 ## - LOCAL CONTROL INFORMATION (RLIN) |
|---|
| -- |
20001010 |
| Operator's initials, OID (RLIN) |
Elda R |
| Cataloger's initials, CIN (RLIN) |
Elda Raphael |
| 998 ## - LOCAL CONTROL INFORMATION (RLIN) |
|---|
| -- |
20160310 |
| Operator's initials, OID (RLIN) |
1048^b |
| Cataloger's initials, CIN (RLIN) |
Larissa |
